Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty
about
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infectionsEfficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trialsTitanium-tethered vancomycin prevents resistance to rifampicin in Staphylococcus aureus in vitroThe safety and efficacy of daptomycin versus other antibiotics for skin and soft-tissue infections: a meta-analysis of randomised controlled trials.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry.High-dose daptomycin therapy for staphylococcal endocarditis and when to apply it.Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin.Daptomycin > 6 mg/kg/day as salvage therapy in patients with complex bone and joint infection: cohort study in a regional reference centerA retrospective study of outcomes of device-associated osteomyelitis treated with daptomycin.Antibiotics and antiseptics for preventing infection in people receiving revision total hip and knee prostheses: a systematic review of randomized controlled trials.Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations.Real-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-CORE.Success after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus.Daptomycin use in patients with osteomyelitis: a preliminary report from the EU-CORE(SM) databaseThe safety and efficacy of high-dose daptomycin combined with rifampicin for the treatment of Gram-positive osteoarticular infections.Current pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.Current concepts in the management of prosthetic joint infection.An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.Clinical experience with the use of daptomycin in a tertiary care teaching hospital in Barcelona, Spain.Daptomycin plus fosfomycin, a synergistic combination in experimental implant-associated osteomyelitis due to methicillin-resistant Staphylococcus aureus in rats.Study on daptomycin use and implementation of an antimicrobial stewardship program.Neutropenia associated with prolonged daptomycin use.Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection.Orthopaedic device-related infection: current and future interventions for improved prevention and treatment.
P2860
Q26752922-85250E2E-477D-438B-BD6F-B1D663FC8CEFQ27000445-FA294D06-4BDE-4949-BDD2-D2CD24A41F60Q28484511-8E44FE6C-4C28-4146-94C6-1273616D3523Q33834856-9E0A5163-C530-406B-9C50-2FE379EDFDE4Q34478074-1850CB2D-753B-4FC9-A075-1EF38BB9CDA9Q35802607-B6C28C76-9C06-4A27-AA08-E55C46832260Q35848781-0AA1FD5A-A9F1-469A-B1AF-9D0B0BC57EEFQ35910321-F5D2641A-E4A9-4A84-B014-991514AAB34EQ35926840-A6086690-9B7C-4A99-AD0C-2D94259FC62BQ36061532-DFC23E23-A7AB-495D-B88D-19BC8B0DF6E0Q36220745-6250C9EF-41B8-4875-B9A2-EFB043B46DA0Q36644902-D28AE43A-41A3-473C-98E5-1BA5C22069EAQ36686882-A953B02C-63D9-4628-9078-CAA0E05C27C0Q36912994-23223002-AA1D-4CEE-85D6-2FE0165011ADQ36929393-0FB4B791-2959-4200-9C53-95D27572CF3BQ36937759-5872D88F-4B23-44FE-9BBC-06FCA3149342Q38089918-0C845F72-A7F5-4762-838D-6281BAADAE1AQ38221335-473386EA-ADC6-4492-BACB-63216D19537CQ38314400-07A929C5-9A6E-4E48-9AB5-30D9606F91E9Q38990504-D10012E4-7823-4823-AD39-521B1C16DC7DQ39182290-D6934A76-6306-43F1-842E-EE144D174A66Q40764649-6BC11F69-E98F-4BD8-A0B5-B327A1A0C68CQ46024308-D1734739-9954-4122-A448-F3431465BF5FQ47152493-847A266C-9877-46D4-9B46-44DF87C1D879Q50893725-C588EC8B-1390-48A8-BF03-13E8B7D1E4A4
P2860
Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Randomized controlled trial of ...... wo-stage revision arthroplasty
@ast
Randomized controlled trial of ...... wo-stage revision arthroplasty
@en
type
label
Randomized controlled trial of ...... wo-stage revision arthroplasty
@ast
Randomized controlled trial of ...... wo-stage revision arthroplasty
@en
prefLabel
Randomized controlled trial of ...... wo-stage revision arthroplasty
@ast
Randomized controlled trial of ...... wo-stage revision arthroplasty
@en
P2093
P2860
P356
P1476
Randomized controlled trial of ...... wo-stage revision arthroplasty
@en
P2093
Diane Anastasiou
Ed Campanaro
Gennady Kuropatkin
Ivor Byren
Richard Evans
Sara Yankelev
Shruta Rege
P2860
P304
P356
10.1128/AAC.00038-12
P407
P577
2012-08-20T00:00:00Z